Home - Products - Apoptosis - Apoptosis - BFC1108

BFC1108

CAS No. 692774-37-1

BFC1108( —— )

Catalog No. M37521 CAS No. 692774-37-1

BFC1108 targets Bcl-2 and converts it to a pro-apoptotic protein, inhibits the growth of triple-negative breast cancer xenografts with high Bcl-2 expression, inhibits breast cancer lung metastasis, and induces apoptosis of Bcl-2-expressing cancer cells.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	71	Get Quote
5MG	103	Get Quote
10MG	170	Get Quote
25MG	352	Get Quote
50MG	569	Get Quote
100MG	894	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

BFC1108
Note

Research use only, not for human use.
Brief Description

BFC1108 targets Bcl-2 and converts it to a pro-apoptotic protein, inhibits the growth of triple-negative breast cancer xenografts with high Bcl-2 expression, inhibits breast cancer lung metastasis, and induces apoptosis of Bcl-2-expressing cancer cells.
Description

BFC1108 targets Bcl-2 and converts it to a pro-apoptotic protein, inhibits the growth of triple-negative breast cancer xenografts with high Bcl-2 expression, inhibits breast cancer lung metastasis, and induces apoptosis of Bcl-2-expressing cancer cells.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Apoptosis
Target

Apoptosis
Recptor

Apoptosis
Research Area

——
Indication

——

Chemical Information

CAS Number

692774-37-1
Formula Weight

424.88
Molecular Formula

C23H21ClN2O4
Purity

>98% (HPLC)
Solubility

——
SMILES

O=C(NC1=CC=C(Cl)C=C1C(=O)NC=2C=CC=CC2OCC)C3=CC=C(OC)C=C3
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

MY-1076

MY-1076 is a potent YAP inhibitor with antigastric cancer activity.MY-1076 dose-dependently induced G2/M phase block, induced YAP degradation and apoptosis, and inhibited microtubule protein polymerization.
Glycerol trioleate

Glyceryl Trioleate has been investigated for the treatment of Adrenoleukodystrophy.
FR054 (b)

FR054 is an inhibitor of the Hexosamine Biosynthetic Pathway (HBP) enzyme PGM3, with a remarkable anti-breast cancer effect.

Sign In Join Free